Changes in Decentering Across Cognitive Behavioral Group Therapy for Social Anxiety Disorder

Behavior Therapy
Sarah A Hayes-Skelton, Carol S Lee

Abstract

To further improve treatments, we need to better understand potential common treatment mechanisms, such as decentering, or the ability to observe thoughts and feelings as objective events in the mind rather than personally identifying with them (Safran & Segal, 1990). Therefore, this study examined whether 12 sessions of Cognitive Behavioral Group Therapy (CBGT) for 63 clients (57.6% female, 50.8% White) diagnosed with social anxiety disorder led to increases in decentering and whether increased decentering was associated with improved outcome. Furthermore, this study examined whether decentering was associated with outcome over and above a competing mechanism-cognitive reappraisal. Overall, results indicated that CBGT in this study led to similar outcomes compared to previous studies and decentering increased over CBGT (d's from 0.81 to 2.23). Change in decentering predicted improvement on most, but not all, measures of outcome and those who no longer met criteria for social anxiety disorder at posttreatment had significantly greater change in decentering across therapy and significantly higher decentering scores at post-treatment compared to those who retained a social anxiety disorder diagnosis at posttreatment. Finally, cha...Continue Reading

References

Apr 1, 1992·Archives of General Psychiatry·F R SchneierM M Weissman
Jan 1, 1987·Modern Problems of Pharmacopsychiatry·M R Liebowitz
Jul 1, 1995·Behaviour Research and Therapy·D A HopeM A Bruch
Mar 1, 1996·Journal of Behavior Therapy and Experimental Psychiatry·S Taylor
Aug 1, 1997·Behaviour Research and Therapy·R M Rapee, R G Heimberg
Dec 23, 1998·Archives of General Psychiatry·R G HeimbergD F Klein
Jul 14, 1999·Behaviour Research and Therapy·J D Teasdale
Feb 24, 2001·Journal of Abnormal Psychology·C R Hirsch, A Mathews
Jun 2, 2001·Journal of Clinical Psychopharmacology·I C Fedoroff, S Taylor
Jun 13, 2001·Behaviour Research and Therapy·A Wells, C Papageorgiou
Jul 4, 2001·Clinical Psychology Review·N Heinrichs, S G Hofmann
Dec 1, 2001·The American Journal of Psychiatry·D J KatzelnickC P Helstad
Jun 8, 2002·Behaviour Research and Therapy·Sandra L BakerStefan G Hofmann
Sep 20, 2002·Clinical Psychology Review·Jane M Spurr, Lusia Stopa
Nov 30, 2002·Behaviour Research and Therapy·Karin Mogg, Brendan P Bradley
Nov 19, 2003·Journal of Consulting and Clinical Psychology·David M ClarkBeverley Louis
Jun 14, 2006·Cognitive Therapy and Research·Stefan G Hofmann, Nina Heinrichs
Jan 5, 2007·Psychological Bulletin·Yair Bar-HaimMarinus H van IJzendoorn
Jun 15, 2007·Journal of Consulting and Clinical Psychology·David M FrescoSydney Kennedy
Aug 25, 2007·Annual Review of Clinical Psychology·Alan E Kazdin
Nov 17, 2007·Behaviour Research and Therapy·Michelle G CraskeAaron Baker
May 30, 2008·Psychological Medicine·C AcarturkR de Graaf
Nov 6, 2008·Social Cognitive and Affective Neuroscience·Norman A S FarbAdam K Anderson
Jan 1, 2006·Journal of Cognitive Psychotherapy·Stefan G Hofmann, Lisa A Scepkowski
Apr 15, 2011·Psychotherapy Research : Journal of the Society for Psychotherapy Research·Louis G Castonguay
Apr 20, 2011·Emotion·Joshua Ian DavisKevin N Ochsner
Apr 25, 2013·Behavior Therapy·Douglas S MenninJames J Gross
May 8, 2013·Journal of Consulting and Clinical Psychology·Sarah A Hayes-SkeltonSusan M Orsillo
Nov 18, 2014·Journal of Consulting and Clinical Psychology·Sarah A Hayes-SkeltonSusan M Orsillo
Dec 23, 2014·Journal of Clinical Psychology·Alice R NortonCaroline Hunt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.